Publications by authors named "F W Albers"
Background: Higher concentration of insulin-like growth factor-1 (IGF-1) increases postmenopausal breast cancer risk, but evidence for insulin and c-peptide is limited. Further, not all studies have accounted for potential confounding by biomarkers from other biological pathways, and not all were restricted to estrogen receptor (ER)-positive breast cancer.
Methods: This was a case-cohort study of 1,223 postmenopausal women (347 with ER-positive breast cancer) from the Melbourne Collaborative Cohort Study.
Article Synopsis
- The study examined how different macronutrient intakes vary among adults based on their economic status and how these dietary patterns relate to health issues like central obesity and inflammation.* -
- Researchers analyzed data from over 41,000 US participants and identified four distinct dietary patterns, discovering that higher economic status correlates with diets rich in fats and proteins, while lower status is linked to higher saturated fat and low alcohol consumption.* -
- Findings revealed that a high saturated fat diet is associated with greater waist circumference and increased levels of inflammatory marker C-reactive protein, suggesting a link between economic status, dietary choices, and metabolic health.*
Purpose: Decentralized clinical trials, where trial-related activities occur at locations other than traditional clinical sites(eg participant homes, local healthcare facilities), have the potential to improve trial access for people for whom time and/or distance constraints may impede participation. Albuterol-budesonide 180/160 µg pressurized metered-dose inhaler (pMDI) is FDA approved for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years or older. BATURA (NCT05505734) is a fully decentralized study, investigating as-needed albuterol-budesonide in participants with mild asthma.
View Article and Find Full Text PDFThis summary describes the results of a clinical study called MANDALA that was published in the in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both and in a single inhaler (known as , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
View Article and Find Full Text PDF